<DOC>
	<DOCNO>NCT01069900</DOCNO>
	<brief_summary>The primary focus study evaluation safety treatment moxifloxacin pediatric population 3 month &lt; 18 year old . Approximately 450 pediatric subject complicate intra-abdominal infection enrol study treat either moxifloxacin intravenously orally switched oral therapy ertapenem ( intravenously ) , switch oral therapy , amoxicillin/clavulanate .</brief_summary>
	<brief_title>Moxifloxacin Pediatric Subjects With Complicated Intra-abdominal Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Hospitalized male female 3 month 17 year age Able obtain parental legal guardian write informed consent assent subject applicable local law regulation Expected duration treatment antibiotic minimum 3 day administer IV , total 5 14 day administer IV IV follow PO If subject female childbearing potential must negative pregnancy test screen visit capable practice adequate method contraception , agree continue method 1 month follow TOC visit . Lactating subject include . Subjects may enrol upon surgically ( laparotomy , laparoscopy , percutaneous drainage ) confirm cIAI revealing least one following : Gross peritoneal inflammation purulent exudate within abdominal cavity Intraabdominal abscess Macroscopic intestinal perforation diffuse peritonitis OR Subjects may enrol basis suspect cIAI , must support radiological evidence ( ultrasound , abdominal plain film , compute tomography [ CT ] , magnetic resonance image [ MRI ] ) gastrointestinal perforation localize collection potentially infect material least one following : Symptoms referable abdominal cavity ( eg , anorexia , nausea , vomit pain ) Tenderness ( without rebound ) , involuntary guarding , absent diminish bowel sound , abdominal wall rigidity Fever Leukocytosis The subject must schedule surgical procedure ( laparotomy laparoscopy ) percutaneous drainage . Presumed spontaneous bacterial peritonitis All pancreatic process include pancreatic sepsis , peripancreatic sepsis , cIAI secondary pancreatitis Early acute suppurative ( nonperforated ) appendicitis unless evidence abscess peritoneal fluid contain pu microorganism suggestive regional contamination Infections originate female genital tract Known severe immunosuppression . Subjects know mild immunosuppression ( eg , Type I II diabetes mellitus , trauma , absolute neutrophil count [ ANC ] 1000 1500 cells/mm3 ) may enrol . Congenital document acquire QT prolongation Receiving concomitant treatment QT prolong drug History tendon disease/disorder relate quinolone treatment Pathogenic organism suspect identify ( eg , Pseudomonas ) resistant study drug Abnormal musculoskeletal finding baseline assessment ; chronic musculoskeletal disease ( eg , juvenile rheumatoid arthritis ) ; chronic illness high risk chronic recurrent arthritis tendinitis ( eg , cystic fibrosis , chronic inflammatory bowel disease ) History myasthenia gravis</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Intra-abdominal infection</keyword>
	<keyword>Pediatric infection</keyword>
</DOC>